NCT00778401View on ClinicalTrials.gov

Bioequivalence Study of Gabapentin 800 mg Tablets Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

October 31, 2002

Study Completion Date

December 31, 2002

Conditions
Healthy
Interventions
DRUG

Gabapentin tablets 800 mg

Trial Locations (1)

58104

PRACS Institute Ltd., Fargo

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00778401 - Bioequivalence Study of Gabapentin 800 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter